Image-1 (Image 1)
Tezruly Solution
Product Images NDC 70954-592
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tezruly (NDC 70954-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-2 (Image 2)
Image-3 (Image 3)
Image-4 (Image 4)
Label (Label)
This text provides information on a medication called TERAZULY, which contains 1 mg/mL of terazosin. It is distributed by ANI Pharmaceuticals, Inc. The prescription information and storage guidelines are included, such as storing at 20-25°C, with excursions permitted up to 30°C. The medication is for oral use, and it is advised to keep the container tightly closed and out of reach of children. Additionally, the text instructs pharmacists to dispense the enclosed patient information leaflet to each patient.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
